Abstract
The study was undertaken in order to compare single injection indocyanine green (ICG)-clearances with the steady-state ICG-clearance (ICGCl ) in patients with cirrhosis in order to assess the most accurate estimate for ICG-clearance and to relate the ICG-clearances to established indicators of liver dysfunction. Thirty-eight patients (male 29) with cirrhosis (Child-Turcotte class A 8, class B 21, and class C 9) were studied during a hemodynamic investigation. A single injection of ICG was followed by blood samples for 5, 10, 15, and 20min. The dose/plasma area clearance (ClA ) and plasma volume·initial slope clearance (ClPV ) were determined and compared with the steady-state infusion/plasma concentration ratio clearance (ICGCl ). The ClA (310; 214; 502mL/min) and ClPV (294; 164; 481mL/min) correlated closely with ICGCl (243; 120; 383mL/min [median; interquartile range], R=0.95-0.98, P<0.000), but were significantly higher than ICGCl (P<0.001). All three clearance measures correlated significantly with biochemical and hemodynamic variables of liver dysfunction (P<0.05-0.000). All three ICG-clearances showed significantly lower values in patients with ascites compared to those without, and lower ICG-clearance values were present in patients with esophageal varices compared to those without (P<0.05-0.002). Single injection markers (ClA and ClPV ) of the steady-state ICG-clearance as derived from the ICG-retention curve and the plasma volume correlate with ICGCl and established variables of portal hypertension and liver cell bile excretory dysfunction. Therefore, these markers can safely replace the more costly ICGCl .
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have